Graphene as cancer theranostic tool: progress and future challenges - Wikidata - wikimedia - TriplyDB

Graphene as cancer theranostic tool: progress and future challenges

Graphene as cancer theranostic tool: progress and future challenges

http://www.wikidata.org/entity/Q26860274

about

Synthesis, toxicity, biocompatibility, and biomedical applications of graphene and graphene-related materials Current Approaches of Photothermal Therapy in Treating Cancer Metastasis with Nanotherapeutics Porous Pt Nanoparticles with High Near-Infrared Photothermal Conversion Efficiencies for Photothermal Therapy.Electrochemically stimulated drug release from flexible electrodes coated electrophoretically with doxorubicin loaded reduced graphene oxide.Self-Assembled Carbon Dot Nanosphere: A Robust, Near-Infrared Light-Responsive, and Vein Injectable Photosensitizer.Mini Review: Nanosheet Technology towards Biomedical Application Radio-graphene in Theranostic Perspectives.Magnetic and fluorescent carbon-based nanohybrids for multi-modal imaging and magnetic field/NIR light responsive drug carriers.Carbon nanohorns allow acceleration of osteoblast differentiation via macrophage activation.Cancer-Targeted Nanotheranostics: Recent Advances and Perspectives.Nanotechnology in Glycomics: Applications in Diagnostics, Therapy, Imaging, and Separation Processes.Two-Dimensional Nanomaterials for Cancer Nanotheranostics.Recent advances in carbon based nanosystems for cancer theranostics.Graphene Oxide-Gallic Acid Nanodelivery System for Cancer Therapy The application of titanium dioxide, zinc oxide, fullerene, and graphene nanoparticles in photodynamic therapy.Redox-active nanomaterials for nanomedicine applications.Design of Block Copolymer Micellar Aggregates for Co-Delivery of Enzyme and Anticancer Prodrug.Graphene oxides and the angiogenic process.Black Phosphorus Nanosheets as a Robust Delivery Platform for Cancer Theranostics.Multifunctional nanoparticles with controllable dimensions and tripled orthogonal reactivity.Nanomaterials for cancer immunotherapy.Hyaluronic acid and Arg-Gly-Asp peptide modified Graphene oxide with dual receptor-targeting function for cancer therapy.A Versatile and Clearable Nanocarbon Theranostic Based on Carbon Dots and Gadolinium Metallofullerene Nanocrystals.Inhibition of the proteasome activity by graphene oxide contributes to its cytotoxicity.Few-Layer Graphene Kills Selectively Tumor Cells from Myelomonocytic Leukemia Patients.Exploring the photothermal hot spots of graphene in the first and second biological window to inactivate cancer cells and pathogens Molecular and Genomic Impact of Large and Small Lateral Dimension Graphene Oxide Sheets on Human Immune Cells from Healthy Donors Trends towards Biomimicry in Theranostics

P2860

Q26745949-8E7732B7-C87F-4F29-9E45-7810D0C55BDD Q26751009-10CB5711-8F06-4DE1-B5DE-CAF48689B50F Q36196867-3D5D8A3D-776F-4C1D-A9ED-83FA4EF02CF7 Q36321816-B04E66DD-DBD4-43F6-BA48-B2F52786AE9B Q36337823-750D5695-FFAD-493B-BC01-539B72528D22 Q38635029-136A5381-0401-4994-85CB-F56B4688EF4A Q38751716-E8BE2760-3CF7-4A76-8DCD-4C6249DC76AE Q38835517-459F3212-0083-4881-8361-0C8DC51E5E5E Q38842163-DCE024E9-FB1A-449F-A42B-FDA3D4EDD8BF Q38870923-66B6D16D-0AEF-4782-A74E-A1995C224909 Q39012279-F8E1368E-3664-444B-AF7C-E91ABFEB4A26 Q39079409-92C5942D-0B69-4A49-9DF8-595F5F788416 Q39236622-34AAD8AD-1D62-4A68-BBC8-C3EDCB4B7E18 Q41774643-75376D9B-BABD-4077-9F53-AD9F5CCD6495 Q44453117-D72E2F6F-EC04-42E1-8721-E52E9854DA09 Q46290936-920F532B-346F-43D8-B1D4-6F45DA589AAA Q46446276-AEAE79D5-4F51-44EC-8E47-D18F49550B86 Q46661982-422F72E3-6BDD-4853-B9D1-BD4FBB4F0492 Q47149280-674D38DA-523A-49A0-A42E-06260539DDF5 Q47627410-0B461E17-CD63-4421-AF82-DFC1D8535609 Q48646732-3A3EF76B-EE5C-434C-B7A1-43627B8C1CF2 Q50860055-67CFF4B7-6F5B-44E8-BB8C-CD0488354E00 Q51262828-4396E929-C840-40B0-89ED-9DC97A5092E6 Q52714042-993BE050-D522-4683-87BE-449644FA027C Q53529505-A6644E73-0EC9-4F02-AA11-587F0E169748 Q57377175-21F2C60E-AAC0-4B1A-9AD1-472A7E8FFB55 Q58234437-E90210BA-D7E6-42E6-8E90-13DE85B355D0 Q58725639-BC4F57A1-435D-4113-9A81-E8B2A64D9D2F

P2860

Graphene as cancer theranostic tool: progress and future challenges

http://www.wikidata.org/entity/Q26860274

description

2015 nî lūn-bûn

@nan

2015 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մարտին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Graphene as cancer theranostic tool: progress and future challenges

@ast

Graphene as cancer theranostic tool: progress and future challenges

@en

Graphene as cancer theranostic tool: progress and future challenges

@nl

type

label

Graphene as cancer theranostic tool: progress and future challenges

@ast

Graphene as cancer theranostic tool: progress and future challenges

@en

Graphene as cancer theranostic tool: progress and future challenges

@nl

prefLabel

Graphene as cancer theranostic tool: progress and future challenges

@ast

Graphene as cancer theranostic tool: progress and future challenges

@en

Graphene as cancer theranostic tool: progress and future challenges

@nl

P1433

Q26860274-77BD40B8-B4E7-45C6-895F-746ED8647837

P1476

Q26860274-337A7D5B-008A-4CE9-9030-D70D8A59A78E

P2093

Q26860274-26E859B8-4881-44A7-8E5D-87CB50D71E54

Q26860274-7F4C7F30-AF11-4279-8EEB-E8EE3AB46720

Q26860274-A40BEB6F-1570-4655-B3A3-034DE58F9A14

P2860

Q26860274-0167DE76-BAD2-47E0-931C-18CD52219AEA

Q26860274-022E268F-2588-4AF8-9CBE-5DDD0FCB8DA8

Q26860274-03F21CA4-A277-4341-B214-BBDF718524AA

Q26860274-04EFE3D9-0E60-4A77-BBEC-D4D3DBA50E61

Q26860274-0807DA3F-D8F2-4200-BCA7-1802400AA139

Q26860274-08C883DF-2219-4FD5-AF9F-0B63C9B6E4A8

Q26860274-08FBEB0A-70B0-46DC-9108-E4F041EE0F1D

Q26860274-09F8F3E3-90A7-4533-8476-7C552EE55816

Q26860274-0D3FD4FB-E5B0-4EDA-BD4B-04CED57DCE92

Q26860274-0D780E27-03F6-48C8-93DD-D5AF96B2B8D0

P304

Q26860274-9EA27590-385E-4551-9216-34E8A91D24FE

P31

Q26860274-9687B14E-140A-4403-B2DC-828C744BBCF0

Q26860274-DB92A82E-ED23-460A-A3B5-07BCDA9D50F1

P3181

Q26860274-B825AD86-E29C-4A41-B230-40A6F996E255

P356

Q26860274-D85C2C56-924F-49FA-A1DD-E103B72D7B5C

P407

Q26860274-6FAC51D3-F9CF-475A-BBBE-D4F27043C469

P433

Q26860274-00B551E5-3E67-431C-9E77-B64747461511

P478

Q26860274-6FEC62FB-6243-41CA-9CF2-E17DF748A453

P50

Q26860274-405134D9-935D-4321-BB92-296CE3DAD870

P577

Q26860274-4F994BF3-1507-452A-9191-735C1D84C920

Q26860274-D24D3BF3-41E2-4989-89F2-663DFB0D5BA4

P5875

Q26860274-E13DEFBE-6960-47F5-BA81-60DB9D149019

P698

Q26860274-08DCACF3-EE47-48CF-96D5-59EE7A98767A

P921

Q26860274-0060D989-9D31-45D8-A7BC-0676EEEC7E82

Q26860274-AA486E45-6462-44C6-8A1E-0B2A342CEFD4

Q26860274-B80DCF89-3A9E-486E-87DA-280987104330

Q26860274-E0970AFE-927D-409A-A2C1-242D66491E72

P932

Q26860274-158068DF-BC4F-493F-8F8B-AC81EC6B0689

P3181

P356

P1433

P1476

Graphene as cancer theranostic tool: progress and future challenges

@en

P2093

Alberto Bianco

http://www.w3.org/2001/XMLSchema#string

Lucia Gemma Delogu

http://www.w3.org/2001/XMLSchema#string

Roberto Cabizza

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

The rise of graphene

Carbon nanotubes: an emerging drug carrier for targeting cancer cells

Impact of carbon nanotubes and graphene on immune cells

Functionalized graphene oxide mediated adriamycin delivery and miR-21 gene silencing to overcome tumor multidrug resistance in vitro

Cancer in developing countries: the next most preventable pandemic. The global problem of cancer.

Functionalized multiwalled carbon nanotubes as ultrasound contrast agents.

Unique diagnostic and therapeutic roles of porphyrins and phthalocyanines in photodynamic therapy, imaging and theranostics

A graphene quantum dot photodynamic therapy agent with high singlet oxygen generation.

P304

710-23

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1823248

http://www.w3.org/2001/XMLSchema#string

P356

10.7150/THNO.11387

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Marco Orecchioni

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2015-03-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277633597

http://www.w3.org/2001/XMLSchema#string

P698

25897336

http://www.w3.org/2001/XMLSchema#string

P921

inorganic compound

pharmaceutical preparation

P932

4402495

http://www.w3.org/2001/XMLSchema#string